Kimberly PringleMaritza PatziJacqueline E. TateVolga Iñiguez RojasManish M. PatelLucia Inchauste JordanRaúl MontesanoAdolfo ZarateLúcia de OliveiraUmesh D. Parashar2026-03-222026-03-22201610.1093/cid/civ1026https://doi.org/10.1093/cid/civ1026https://andeanlibrary.org/handle/123456789/45109Citaciones: 32A monovalent rotavirus vaccine remains effective against a broad range of circulating strains as part of a routine immunization program >5 years after its introduction in Bolivia. Although VE appears to wane in children aged ≥1 year, it still provides significant protection, and does not wane against severe disease.enMedicineRotavirusRotavirus vaccineVirologyRotavirus InfectionsReoviridaearticle